You’ve hit your search limit
Start your free trial to keep exploring full traffic and performance insights.
Get StartedQGenome analisi dell'app per 11 gennaio
QGenome
- UBQO Limited
- App Store di Apple
- Gratis
- Settore Medico
QGenome has been developed by Guy's and St Thomas' NHS Foundation Trust's Regional Genetics service, a partner in the South East Genomic Medicine Service Alliance, and UBQO to provide streamlined inherited genomic risk assessment, testing and referral guidance in an accessible and user-friendly format.
QGenome enables users to decide which patients may be eligible for genomic investigations and risk assessment, in line with the NHSE Genomic Test Directory and published literature. It provides clinicians with a framework of questions that can be used in their clinical approach when managing patients who are concerned about an inherited susceptibility to disease.
The application allows users to access up to date clinical guidance, at the ‘point of care’, and delivers a time-efficient mechanism to instigate genomic evaluation and onward referrals, where necessary.
The aim of QGenome is to facilitate streamlined quicker access to enhanced surveillance, risk-reduction options, genetic counselling, genomic testing and multidisciplinary care for patients and their families.
Classifica degli store
La classifica del store si basa su diversi parametri stabiliti da Google e Apple.
Tutte le categorie in
Stati Uniti--
Settore Medico in
Stati Uniti--
Crea un account per visualizzare il numero mensile medio di downloadContattaci
QGenomeStatistiche di ranking nel tempo
Classifica di Utilizzo di Similarweb e Classifica App Store di Apple per QGenome
Rank
Nessun dato disponibile
QGenome Classifica per paese
Paesi in cui QGenome ha la posizione più alta nelle sue categorie principali
Nessun dato da visualizzare
Principali concorrenti e app alternative
App con un'alta probabilità di essere utilizzate dagli stessi utenti, provenienti dallo stesso store.
GenomYou
genomsys sa
Genomes.io
Genomesio LTD
My Toolbox Genomics
GENEIUS HEALTH LLC
iatroX
Kolawole Tytler
gennaio 11, 2026